首页> 外国专利> Novel Tetranuclear Arene-Ruthenium Compound and Parmaceutical Composition for Preventing or Treating Cancer Containing Thereof

Novel Tetranuclear Arene-Ruthenium Compound and Parmaceutical Composition for Preventing or Treating Cancer Containing Thereof

机译:用于预防或治疗含四核芳烃的新型四核芳族钌化合物和药物组合物

摘要

PURPOSE: A novel tetranuclear arene-ruthenium compound is provided to show superior anticancer effect and to prevent and treat cancer. CONSTITUTION: A tetranuclear arene-ruthenium compound or a pharmaceutically acceptable salt thereof is provided. A pharmaceutical composition for preventing or treating cancer contains the compound or a pharmaceutically acceptable salt thereof as an active ingredient. The compound or a pharmaceutically acceptable salt thereof shows an anticancer activity through cancer cell apoptosis. The cancer is solid cancer. [Reference numerals] (AA) 1+2 = 4a+4b (comparative example 1); (BB) 1+3 = 5a+5b (example 1)
机译:目的:提供一种新型的四核芳烃钌化合物,以显示出优异的抗癌作用并预防和治疗癌症。组成:提供了一种四核芳烃-钌化合物或其药学上可接受的盐。预防或治疗癌症的药物组合物含有该化合物或其药学上可接受的盐作为有效成分。该化合物或其药学上可接受的盐通过癌细胞凋亡显示出抗癌活性。癌症是实体癌。 [附图标记](AA)1 + 2 = 4a + 4b(比较例1); (BB)1 + 3 = 5a + 5b(示例1)

著录项

  • 公开/公告号KR101360514B1

    专利类型

  • 公开/公告日2014-02-13

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20120025590

  • 发明设计人 지기환;송영호;

    申请日2012-03-13

  • 分类号A61K31/555;C07F15;A61K33/24;A61P35;

  • 国家 KR

  • 入库时间 2022-08-21 15:41:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号